In this webinar on “Accessing The Chinese Market: A Perspective From Two Start-Ups”, Dr. Likun Wang, Mrs. Yang Feng and Dr. Li Wei will share their knowledge on emerging areas in pharmaceutical developments, experiences entering the China pharma market and the network that supported them going through this entrepreneurial journey.
Duke-NUS Bio-Entrepreneur Series – A Scientist’s Journey to Entrepreneurship – the Story of Enleofen: Post Event Write-up
The second webinar of the series titled “A Scientist’s Journey to Entrepreneurship – The story of Enleofen” was moderated by Ms. Sabrina Ng, Chief Finance Officer, CXA Group and featured Dr. Sebastian Schaefer, Assistant Professor, Cardiovascular and Metabolic Disorder, Duke-NUS Medical School.
In this EVX-BCS webinar, Professor Andrew Lo from the MIT Sloan School of Management will explain how the tools of financial engineering—portfolio theory, securitization, credit default swaps, and other commonly used financial techniques—can be used to reduce the risk and increase the attractiveness of biomedical innovation so as bring new therapies to patients faster.
In this EVX-BCS webinar on the journeys of three scientists in biotech, Dr Tan Si Hui, Dr Wai Lu-En, and Dr. Lee Yin Loon will share with us their journeys from academia to biotech start-ups. This panel of scientists will introduce to us a path for those with a spirit of creativity, courage and capability to bring their scientific discoveries to the market.
This November, join our second Future of Healthcare Week where 2,000+ healthcare leaders will explore how to navigate the opportunities and challenges around innovation, accessibility, efficiency, sustainability and the inevitable acceleration of digital healthcare that the pandemic has catalysed.
In this post-event summary, we revisit a webinar hosted by BCS on 23rd September 2020, featuring Bianca Coulter, Martin Grindrod and Neha Rajdev of Coulter Partners, a global Life Science board and senior level executive search firm.
The BCS Startup Series – Funding schemes for Innovation Enterprises in Singapore: Post Event Write-up
In this instalment of the BCS Startup Series on funding schemes, we invite managers and program directors from National Health Innovation Centre (NHIC) Singapore and SME Centre @ Singapore Indian Chamber of Commerce and Industry (SME Centre@SICCI), an initiative of Enterprise Singapore, to share with us about the capability assistance programmes and other programs under the same initiative (i.e. Startup SG programs), that businesses can explore and some useful information about the application process.
Regulations are made by the government to protect public health by ensuring the safety and efficacy of medicines, vaccines, and medical devices. Based on regional and economic constraints, the regulatory bodies around the globe differ in their guidelines, making it challenging even for regulatory affairs professionals to navigate. To aid in the understanding of these variations, BCS recently organised a three-part webinar-based workshop series on regulatory affairs, given by experts in different domains of regulation in Asia, Europe, and America.
As part of COVID-19 webinar series, Biotech Connection Singapore (BCS) hosted speakers from academic and industry settings to discuss advances in the research community under the new ‘norm’, as well as the research efforts undertaken in facilitating basic and translational research in the fight against SARS-COV-2. The panel included:
Dr. Ooi Eng Eong, Professor and Deputy Director of the Emerging Infectious Diseases Programme at Duke-NUS Medical School
Mr. Rajeev Nair, Senior VP and Head of APAC Research Solutions, Life Science, Merck
Mr. Mark Dupal, APAC Senior Sales Director of Twist Bioscience
The essential stay home conversations is a series of webinars curated by BCS to explore how the biomedical community is responding to the COVID-19 pandemic and how they contribute to bringing this public health crisis under control. Diagnostic testing or detecting the virus in patients is a critical step in determining the public health response and controlling the outbreak. Following the successful launch of our first webinar with Dr. Timothy Barkham (TTSH) about the efforts undertaken at the front lines of COVID-19 testing, we were honoured to have Dr. Sidney Yee, CEO of Diagnostics Development (DxD) Hub at A*STAR, Dr. Lihan Zhou, co-founder and CEO of MiRXES, and Dr. Tan Min Han, CEO and Medical Director of Lucence, to share the exciting journey of developing and manufacturing these crucial diagnostic kits. The webinar was moderated by Dr Mayura Wagle, Vice President of BCS